Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue

Journal of Clinical Oncology

Volumn 25, Issue 16, 2007, Pages 2236-2242

  Formenti, Silvia C ^a   Gidea Addeo, Daniela ^a   Goldberg, Judith D ^a   Roses, Daniel F ^a   Guth, Amber ^a   Rosenstein, Barry S ^a   DeWyngaert, Keith J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST FIBROSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; CANCER LOCALIZATION; CANCER PAIN; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DERMATITIS; FATIGUE; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PARTIAL MASTECTOMY; PIGMENT DISORDER; PRIORITY JOURNAL; RADIATION DOSE; SKIN MANIFESTATION; TELANGIECTASIA; BODY POSTURE; BREAST TUMOR; FEMALE; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PRONE POSITION; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 34250184673     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.1041     Document Type: Article

References (66)

1. National Institutes of Health Consensus Development Conference statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst Monogr 30:5-15, 2001
2. Joslyn SA: Radiation therapy and patient age in the survival from early-stage breast cancer. Int J Radiat Oncol Biol Phys 44:821-826, 1999
3. Hebert-Croteau N, Brisson J, Latreille J, et al: Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85:1104-1113, 1999
4. Truong MT, Hirsch AE, Formenti SC: Novel approaches to postoperative radiation therapy as part of breast-conserving therapy for early-stage breast cancer. Clin Breast Cancer 4:253-263, 2003
5. Suh WW, Pierce LJ, Vicini FA, et al: A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 62:790-796, 2005
6. Baillet F, Housset M, Maylin C, et al: The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: A randomized study of 230 patients. Int J Radiat Oncol Biol Phys 19:1131-1133, 1990
7. Barendsen GW: Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8:1981-1997, 1982
8. Matthews JH, Meeker BE, Chapman JD: Response of human tumor cell lines in vitro to fractionated irradiation. Int J Radiat Oncol Biol Phys 16:133-138, 1989
9. Thames HD, Bentzen SM, Turesson I, et al: Time-dose factors in radiotherapy: A review of the human data. Radiother Oncol 19:219-235, 1990
10. Fowler J: The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679-694, 1989
11. Whelan T, MacKenzie R, Julian J, et al: Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94:1143-1150, 2002
12. Horton JK, Halle JS, Chang SX, et al: Comparison of three concomitant boost techniques for early-stage breast cancer. Int J Radiat Oncol Biol Phys 64:168-175, 2006
13. Mayo CS, Urie MM, Fitzgerald TJ: Hybrid IMRT plans-concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. Int J Radiat Oncol Biol Phys 61:922-932, 2005
14. Goodman KA, Hong L, Wagman R, et al: Dosimetric analysis of a simplified intensity modulation technique for prone breast radiotherapy. Int J Radiat Oncol Biol Phys 60:95-102, 2004
15. Fraass BA, Kessler ML, McShan DL, et al: Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy. Semin Radiat Oncol 9:60-77, 1999
16. Formenti SC, Truong MT, Goldberg JD, et al: Prone accelerated partial breast irradiation after breast-conserving surgery: Preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 60:493-504, 2004
17. Formenti SC: External-beam partial-breast irradiation. Semin Radiat Oncol 15:92-99, 2005
18. Griem KL, Fetherston P, Kuznetsova M, et al: Three-dimensional photon dosimetry: A comparison of treatment of the intact breast in the supine and prone position. Int J Radiat Oncol Biol Phys 57:891-899, 2003
19. el-Fallah AI, Plantec MB, Ferrara KW: Ultrasonic measurement of breast tissue motion and the implications for velocity estimation. Ultrasound Med Biol 23:1047-1057, 1997
20. Darby SC, McGale P, Taylor CW, et al: Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557-565, 2005
21. Van de Steene J, Vinh-Hung V, Cutuli B, et al: Adjuvant radiotherapy for breast cancer: Effects of longer follow-up. Radiother Oncol 72:35-43, 2004
22. Prosnitz RG, Chen YH, Marks LB: Cardiac toxicity following thoracic radiation. Semin Oncol 32:S71-S80, 2005
23. Prosnitz RG, Marks LB: Radiation-induced heart disease: Vigilance is still required. J Clin Oncol 23:7391-7394, 2005
24. Reference deleted by author.
25. Marks LB, Yu X, Prosnitz RG, et al: The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63:214-223, 2005
26. Recht A: Which breast cancer patients should really worry about radiation-induced heart disease-and how much? J Clin Oncol 24:4059-4061, 2006
27. Ng R, Better N, Green MD: Anticancer agents and cardiotoxicity. Semin Oncol 33:2-14, 2006
28. Valagussa P, Zambetti M, Biasi S, et al: Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. Ann Oncol 5:209-216, 1994
29. Shapiro CL, Hardenbergh PH, Gelman R, et al: Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 16:3493-3501, 1998
30. Guerrero M, Li XA, Earl MA, et al: Simultaneous integrated boost for breast cancer using IMRT: A radiobiological and treatment planning study. Int J Radiat Oncol Biol Phys 59:1513-1522, 2004
31. Lief EP, DeWyngaert J, Formenti SC: IMRT for concomitant boost to the tumor bed for breast cancer radiation therapy. Int J Radiat Oncol Biol Phys 57:S366, 2003
32. Andreassen CN, Alsner J, Overgaard M, et al: Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69:127-135, 2003
33. Lymberis SC, Parhar PK, Katsoulakis E, et al: Pharmacogenomics and breast cancer. Pharmacogenomics 5:31-55, 2004
34. Andreassen CN, Overgaard J, Alsner J, et al: ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 64:776-783, 2006
35. Mitchell J, Rosenstein B, Remon S: Whole breast accelerated IMRT with concomitant boost-dosimetric results in 70 patients. Radiological Society of North America, 92nd Scientific Assembly and Annual Meeting, 353, Chicago, IL, November 26, 2006
36. deWyngaert J, Lymberis SC, MacDonald S: Accelerated IMRT with concomitant boost after breast-conserving therapy (BCT): Preliminary clinical results and dose volume histogram (DVH) analysis. Int J Radiat Oncol Biol Phys 60:S386-S387, 2004
37. deWyngaert J, Jozsef G, Mitchell J: Accelerated Intensity modulated radiation therapy (AIMRT) to the breast in the prone position: Dosimetric results. Int J Radiat Oncol Biol Phys, in press
38. Hoeller U, Tribius S, Kuhlmey A, et al: Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys 55:1013-1018, 2003
39. Lea D, Catcheside DG: The mechanism of the induction by radiation of chromosome aberrations in Trasdescantia. J Genet 44:216-245, 1942
40. Steel G, Deacon J, Duchesnea GM: The dose-rate effect in human tumour cells. Radiother Oncol 9:299-310, 1987
41. Turesson I, Thames H: Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation, and telangiectasia after 3 and 5 years follow-up. Int J Radiat Oncol Biol Phys 15:169-188, 1989
42. Thames H, Bentzen S, Turesson I, et al: Time-dose factors in radiotherapy: A review of the human data. Radiother Oncol 19:219-235, 1990
43. Archambeau JO, Pezner R, Wasserman T: Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 31:1171-1185, 1995
44. Yamada Y, Ackerman I, Franssen E, et al: Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Biol Phys 44:99-104, 1999
45. Travis E, Tucker S: Isoeffect models and fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13:283-287, 1987
46. Stanton PD, Cooke TG, Forster G, et al: Cell kinetics in vivo of human breast cancer. Br J Surg 83:98-102, 1996
47. Haustermans K, Fowler J, Geboes K, et al: Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot? Radiother Oncol 46:157-167, 1998
48. Holland R, Connolly JL, Gelman R, et al: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8:113-118, 1990
49. Bartelink H, Horiot JC, Poortmans P, et al: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378-1387, 2001
50. Reznik J, Cicchetti MG, Degaspe B, et al: Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys 61:163-168, 2005
51. Reed DR, Lindsley SK, Mann GN, et al: Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys 61:358-364, 2005
52. Alonso-Basanta M, MacDonald S, Lymberis S: Dosimetric comparisons of supine versus prone radiation: Implications on normal tissue toxicity. Int J Radiat Oncol Biol Phys 63:S182-S183, 2005
53. Gyenes G, Gagliardi G, Lax I, et al: Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 15:1348-1353, 1997
54. Chen MH, Chuang ML, Bornstein BA, et al: Impact of respiratory maneuvers on cardiac volume within left-breast radiation portals. Circulation 96:3269-3272, 1997
55. Krauss DJ, Kestin LL, Raff G, et al: MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys 61:1243-1250, 2005
56. Raj KA, Evans ES, Prosnitz RG, et al: Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer? Cancer J 12:309-317, 2006
57. Parhar PK, Constantine C, Racsa-Alamgir M: 1082: Preliminary Results of NYU 05-181, a Prospective Trial to Establish the Individual Optimal Positioning for Breast Radiotherapy. Int J Radiat Oncol Biol Phys 66:S177-S177, 2006
58. Patt DA, Goodwin JS, Kuo YF, et al: Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23:7475-7482, 2005
59. Vallis KA, Pintilie M, Chong N, et al: Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol 20:1036-1042, 2002
60. Giordano SH, Kuo YF, Freeman JL, et al: Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419-424, 2005
61. Gyenes G, Fornander T, Carlens P, et al: Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 28:1235-1241, 1994
62. Gyenes G, Fornander T, Carlens P, et al: Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study. Int J Radiat Oncol Biol Phys 36:899-905, 1996
63. Gyenes G, Fornander T, Carlens P, et al: Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy. Eur J Nucl Med 24:286-292, 1997
64. Seddon B, Cook A, Gothard L, et al: Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol 64:53-63, 2002
65. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
66. Hall EJ: Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65:1-7, 2006